Loading...

Brefeldin A Solution (1,000X)

Pricing & Availability
Regulatory Status
RUO
Other Names
BFA
Ave. Rating
Submit a Review
Product Citations
publications
Cat # Size Price Quantity Check Availability Save
420601 1 mL 52€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

Brefeldin A (BFA) is a protein transport inhibitor commonly used to enhance intracellular cytokine staining signals by blocking transport processes during cell activation. Especially useful for the intracellular staining of cytokines, BFA leads to the accumulation of most cytokines at the Golgi Complex/Endoplasmic Reticulum (see Jung, et al., 1993). Optimal conditions for use are cell type and time-dependent. Typically, protein transport inhibitors are included during in vitro cell activation cultures for 4-24 hours prior to harvest (see references below for additional information). Brefeldin A Solution is supplied as a 1,000X solution, which should be diluted to 1X in cell culture medium.

Product Details
Technical Data Sheet (pdf)

Product Details

Formulation
Brefeldin A Solution is supplied as a 1000X in DMSO, which should be diluted to 1X in cell culture medium.
Concentration
5.0 mg/ml
Storage & Handling
Store the Brefeldin A Solution (1,000X) between 2°C and 8°C. Note: DMSO freezes at this temperature.
Application

ICFC - Quality tested
Recommended Usage

Dilute the 1000X solution to 1X in the tissue culture medium. It is recommended that cells are cultured with brefeldin A for ≤ 24 hours, as this can become toxic for cell viability.

Application Notes

Completely thaw the solution before use, DMSO freezes at 4°C.  We recommend aliquotting the reagent into smaller volumes to avoid repeated freeze-thawing.  

Application References
  1. O'Sullivan BJ, et al. 2006. J. Immunol. 176:7278.
  2. Fuse S, et al. 2007. J. Immunol. 178:5227.
  3. Kang YJ, et al. 2007. Nature Immunol. 8:601.
  4. Redfern CH,et al.2006.J. Clin Oncol.19:3107. PubMed
  5. Smithey MJ, et al. 2008. J. Immunol. 180:3406. PubMed
  6. Elzey BD, et al. 2008. Blood 111:38684. PubMed
  7. Nguyen KD, et al. 2008. J. Immunol. 181:5386. PubMed
  8. Miner MD, et al. 2008. Microb Pathog. 45:273. PubMed
  9. Goodridge HS, et al. 2009. J. Immunol. 182:1146. PubMed
  10. Markey KA, et al. 2009. Blood 113:5644. PubMed
  11. Wilcox RA, et al. 2009. Blood PubMed
  12. Zenaro E, et al. 2009. J. Leukoc Bio. PubMed
  13. Rozkova D, et al. 2009. Clin Immunol. 131:1. PubMed
  14. Butcher JP, et al. 2010. Clin Cancer Res. 16:2065.
  15. Boisvert M, et al. 2010. J. Virol. 84:7782. PubMed
  16. Liu WC, et al. 2010. J. Virol. 84:12011.15. Tawara I, et al. 2011. Clin Cancer Res. 17:77. PubMed
  17. Iwata Y, et al. 2011. Blood. 117:530. PubMed
  18. Schmidt NW, et al. 2011. J. Immunol. 186:3836. PubMed
  19. Langkjaer A, et al. 2012. Clin Immunol. 145:1. PubMed
  20. Molinero LL, et al. 2012. PNAS. 109:18529. PubMed
  21. Li HW, et al. 2012. J. Immunol. 189:5572. PubMed
  22. Wang JM, et al. 2013. J. Virol. 87:4372. PubMed
  23. Fukuoka A, et al. 2013. Int Immunol. 25:373. PubMed
  24. Wang Jm, et al. 2013. J Virol. 87:11626. PubMed
  25. Lee TH, et al. 2013. J Biol Chem. 288:32873. PubMed
  26. Shi L, et al. 2014. J. Immunol. 192:649. PubMed
  27. Bulati M, et al. 2014. Exp Gerontol. PubMed
  28. Blankenhaus B, et al. 2014. PLoS Pathog. 10:1003913. PubMed
  29. Tuna H, et al. 2014. J Leukoc Biol. 95:471. PubMed
  30. Miller ML, et al. 2014. PNAS. 111:7397. PubMed
  31. Wang Y, et al. 2014. Sci Rep. 4:5346. PubMed
  32. Zhou GL, et al. 2014. J Cell Sci. 127:3916. PubMed
  33. Rist MJ, et al. 2015. J Virol. 89:703. PubMed
Product Citations
  1. Wang R, et al. 2018. Oncoimmunology. 7:e1461303. PubMed
  2. Wang Y, et al. 2014. Sci Rep. 4:5346. PubMed
  3. Morse M, et al. 2016. Lupus. 25: 81 - 87. PubMed
  4. Li B, Schmidt N 2016. PLoS One. 11: 0162427. PubMed
  5. Rappazzo CG, et al. 2020. bioRxiv. . PubMed
  6. Yakkala C, et al. 2021. Front Immunol. 12:695150. PubMed
  7. Zheng B, et al. 2021. Int J Mol Sci. 22: . PubMed
  8. Alexander KL, et al. 2021. Gastroenterology. 161:522. PubMed
  9. Trinks N, et al. 2021. Commun Biol. 4:1151. PubMed
  10. Chen J, et al. 2022. Adv Healthc Mater. 11:e2101714. PubMed
  11. Zhu S, et al. 2017. Exp Cell Res.. 10.1016/j.yexcr.2017.10.013. PubMed
  12. Li L,et al. 2017. Sci Rep.. 10.1038/s41598-017-14000-z. PubMed
  13. Qian Y, et al. 2021. Cell Reports. 36(8):109602. PubMed
  14. Pablo-Bernal R, et al. 2016. J Gerontol A Biol Sci Med Sci. 71: 610 - 618. PubMed
  15. Tuna H, et al. 2014. J Leukoc Biol. 95:471. PubMed
  16. Xin G, et al. 2021. Cancer Immunol Res. 9:454. PubMed
  17. Rodrigues M, et al. 2022. Biochem J. 479:1891. PubMed
  18. Nesterenko PA, et al. 2021. Cell Rep. 37:110167. PubMed
  19. Lefebvre MN, et al. 2021. Cell Rep. 37:109956. PubMed
  20. Muliaditan T, et al. 2021. Cell Rep Med. 2:100457. PubMed
  21. Fote GM, et al. 2022. J Cell Sci. 135:. PubMed
  22. Aguilar-Pineda JA, et al. 2021. iScience. 24:102993. PubMed
  23. Moudra A, et al. 2021. J Immunol. 206:2109. PubMed
  24. Maschmeyer P, et al. 2017. J Autoimmun.. 10.1016/j.jaut.2017.11.005. PubMed
  25. Yamamoto A, et al. 2019. J Clin Invest. 129:3640. PubMed
  26. Shi L, et al. 2014. J Immunol. 192:649. PubMed
  27. Weng RR, et al. 2021. Nat Commun. 12:2163. PubMed
  28. Kiritsy MC, et al. 2021. Elife. 10:. PubMed
  29. Piper CJM, et al. 2020. Cell Reports. 29(7):1878-1892.e7.. PubMed
  30. Gay MD, et al. 2020. Cancer Prev Res (Phila). . PubMed
  31. Just S, et al. 2016. Sci Rep. 6:39796. PubMed
  32. Liang Q, et al. 2022. iScience. 25:104043. PubMed
  33. Cook CP, et al. 2022. Cell Rep Med. 3:100715. PubMed
  34. Snyder LM, et al. 2021. PLoS Pathog. 17:e1009970. PubMed
  35. Krone A, et al. 2022. Sci Rep. 218:. PubMed
  36. Michaud D, et al. 2022. Front Immunol. 12:745873. PubMed
  37. Nagatake T, et al. 2022. Mucosal Immunol. 15:289. PubMed
  38. Nguyen K, et al. 2008. J Immunol. 181:5386. PubMed
  39. Wilcox R, et al. 2009. Blood. 114:2936. PubMed
  40. Starnbach X 2015. J Immunol. 195: 1665-1675. PubMed
  41. Garg B, et al. 2016. Mutagenesis. 10.1093/mutage/gew023. PubMed
  42. Ruhland M, et al. 2016. Nat Commun. 7:11762. PubMed
  43. Shi Z, et al. 2021. Ann Clin Transl Neurol. 8:43. PubMed
  44. Tang B, et al. 2020. Clin Cancer Res. 26:2216. PubMed
  45. Jtte BB, et al. 2021. iScience. 24(8):102833. PubMed
  46. Almshayakhchi R, et al. 2021. Front Oncol. 11:636977. PubMed
  47. Glaubitz J, et al. 2022. Nat Commun. 13:4502. PubMed
  48. Smithey M, et al. 2008. J Immunol. 180:3406. PubMed
  49. Rana A, et al. 2020. Front Immunol. 11:536. PubMed
  50. Dayoub O, et al. 2017. Sci Rep. 10.1038/s41598-017-09933-4. PubMed
  51. Martens A, et al. 2020. Nat Immunol. 21:381. PubMed
  52. Wang Z, et al. 2020. Autophagy. 1:. PubMed
  53. Jiang S, et al. 2020. Scand J Immunol. e12867:91. PubMed
  54. Hradilova N, et al. 2017. PLoS One. 12(2):e0171539. PubMed
  55. Griffiths K, et al. 2016. Nat Commun. 7:13894. PubMed
  56. Ciarlo E, et al. 2016. Sci Rep. 6:37944. PubMed
  57. Al-Attar A, et al. 2016. Data Brief. 8: 536-44. PubMed
  58. Gonzalez-Perez G, et al. 2016. J Immunol. 196: 3768 - 3779. PubMed
  59. Pablo-Bernal R, et al. 2015. J Infect Dis. 10.1093/infdis/jiv520. PubMed
  60. Blankenhaus B, et al. 2014. PLoS Pathog. 10:1003913. PubMed
  61. Kang X, et al. 2022. Vaccines (Basel). 10:. PubMed
  62. Jeong J, et al. 2021. Immune Netw. 21:e31. PubMed
  63. Jondle CN, et al. 2021. MBio. 12:. PubMed
  64. Yu H, et al. 2011. J Leukoc Biol. 90:205. PubMed
  65. Doll K, et al. 2016. J Immunol. 196: 4253 - 4262. PubMed
  66. Liu W, et al. 2016. J Virol. 90: 6085 - 6096. PubMed
  67. Fucikova J, et al. 2016. Blood. 128(26):3113-3124. PubMed
  68. Douthwaite J, et al. 2017. J Immunol. 198(1):528-537. PubMed
  69. Snyder LM, et al. 2022. Immunohorizons. 6:660. PubMed
  70. Zhao F, et al. 2022. Front Immunol. 13:873720. PubMed
  71. Liu W, et al. 2010. J Virol. 84:12011. PubMed
  72. Elzey B, et al. 2008. Blood. 111:3684. PubMed
  73. Ries M, et al. 2017. PLoS Pathog. 10.1371/journal.ppat.1006506. PubMed
  74. Rialdi A, et al. 2016. Science. 352: aad7993. PubMed
  75. Li H, et al. 2012. J Immunol. 189:5572. PubMed
  76. Carissimo G, et al. 2019. Life Sci Alliance. 2:e201900298. PubMed
  77. Wang Y, et al. 2020. Sci Adv. 6:eaba5412. PubMed
  78. Satoh M, et al. 2016. Sci Rep. 6:28473. PubMed
  79. Codo AC, et al. 2020. Cell Metab. 32:437. PubMed
  80. Littwitz-Salomon E, et al. 2021. Nat Commun. 12:5376. PubMed
  81. Shenoy AT, et al. 2021. Nat Commun. 12:5834. PubMed
  82. Ulrich-Lewis JT, et al. 2022. Front Immunol. 13:861710. PubMed
  83. Elliott PR, et al. 2021. Cell Rep. 37:109777. PubMed
  84. Dumaine JE, et al. 2021. Elife. 10:. PubMed
  85. Cheng B, et al. 2022. Cancer Commun (Lond). 42:17. PubMed
  86. Jondle CN, et al. 2021. J Virol. 95:e0072621. PubMed
  87. Bunting MD, et al. 2022. Sci Adv. 8:eabk3327. PubMed
  88. Uddin MN, et al. 2022. Brain Behav Immun Health. 26:100563. PubMed
  89. Tawara I, et al. 2011. Clin Cancer Res. 0.761805556. PubMed
  90. Orlov M, et al. 2017. PLoS One.. 10.1371/journal.pone.018296. PubMed
  91. Martins M, et al. 2017. PLoS Pathog. 10.1371/journal.ppat.1006529. PubMed
  92. Gross C, et al. 2016. Neurol Neuroimmunol Neuroinflamm. 3: e289. PubMed
  93. Krämer B, et al. 2016. PLoS One. 11: 0162068. PubMed
  94. Crooks SD, et al. 2022. Immunohorizons. 6:705. PubMed
  95. Fang E, et al. 2022. MedComm (2020). 3:e117. PubMed
  96. Cao Y, et al. 2018. Nat Commun. 2.940972222. PubMed
  97. Emmer BT, et al. 2018. Elife. 7:e38839. PubMed
  98. Hassan AO, et al. 2020. Cell. 183:169. PubMed
  99. Harty N 2011. J Immunol. 186:3836. PubMed
  100. Iwata Y, et al. 2011. Blood. 117:530. PubMed
  101. Lee T, et al. 2013. J Biol Chem. 288:32873. PubMed
  102. Vigano S, et al. 2015. J Virol. 89: 7829-7840. PubMed
  103. Vacaflores A, et al. 2016. PLoS One. 11: 0157175. PubMed
  104. Ma H, Wan S, Xia C 2016. J Leukoc Biol. 99: 1121 - 1129. PubMed
  105. Kim J, et al. 2016. Nat Immunol. 17:1159-1166. PubMed
  106. Johnson AM, et al. 2020. J Immunol. 204:2295. PubMed
  107. Buqué A, et al. 2020. Nat Commun. 3.110416667. PubMed
  108. Redfern C, et al. 2006. J Clin Oncol. 24:3107. PubMed
  109. Yan H, et al. 2020. ACS Appl Mater Interfaces. 12:19324. PubMed
  110. Matisz C, et al. 2017. Sci Rep. 7:40631. PubMed
  111. Castro I, et al. 2016. J Virol. 90: 5280 - 5291. PubMed
  112. Zhang W, et al. 2015. Infect Immun . 83: 3213-3223. PubMed
  113. Ji L, et al. 2012. PLoS One. 7:e50909. PubMed
  114. Huang RS, et al. 2021. Curr Protoc. 1:e246. PubMed
  115. Li G, et al. 2021. Curr Protoc. 1:e50. PubMed
  116. Gao Y, et al. 2022. Immunity. 55:1732. PubMed
  117. Han K, et al. 2021. Nat Metab. 3:318. PubMed
  118. Peng L, et al. 2022. Cell Rep Med. 3:100634. PubMed
  119. Bachy S, et al. 2022. iScience. 25:103758. PubMed
  120. Ohtsuka J, et al. 2021. iScience. Online ahead of print. PubMed
  121. Ngwenyama N, et al. 2019. JCI Insight. 4:e125527. PubMed
  122. Good Z, et al. 2019. Nat Biotechnol. 37:259. PubMed
  123. Butchar J, et al. 2010. Clin Cancer Res. 2.100694444. PubMed
  124. Wang J, et al. 2013. J Virol. 87:4372. PubMed
  125. Nice T, et al. 2016. PLoS One. 12: 1005684. PubMed
  126. Pfeifle R, et al. 2016. Nat Immunol. 18:104-113. PubMed
  127. Krishnan A, et al. 2020. Am J Pathol. 190:1284. PubMed
  128. Hiza H, et al. 2021. Sci Rep. 11:13190. PubMed
  129. Grace PS, et al. 2021. Front Immunol. 12:679973. PubMed
  130. Li Y, et al. 2021. Vaccines (Basel). 9:. PubMed
  131. Liu W, et al. 2022. Bio Protoc. 12:e4285. PubMed
  132. Ma K, et al. 2022. iScience. 25:104347. PubMed
  133. Zhang Y, et al. 2022. Vaccines (Basel). 10: . PubMed
  134. Kalafati L, et al. 2020. Cell. 183:771. PubMed
  135. Sekine T, et al. 2020. Cell. 183:158. PubMed
  136. Gogokhia L, et al. 2019. Cell Host Microbe. 25:285. PubMed
  137. Guo C, et al. 2018. Immunity. 49:842. PubMed
  138. Yuan X, et al. 2017. Elife. 6:e29540. PubMed
  139. Rossato C, et al. 2017. Biologicals. 10.1016/j.biologicals.2017.06.007. PubMed
  140. Wang Y, et al. 2020. Virol Sin. 36:122. PubMed
  141. Loeuillard E, et al. 2020. J Clin Invest. 130:5380. PubMed
  142. Matsushita T, et al. 2015. Rheumatology. 101093/rumatology/kv331. PubMed
  143. Molinero L, et al. 2012. Proc Natl Acad Sci U S A. 109:18529. PubMed
  144. Tajima M, et al. 2022. Curr Protoc. 2:e540. PubMed
  145. de Picciotto S, et al. 2022. Nat Commun. 13:3866. PubMed
  146. Michelozzi IM, et al. 2022. STAR Protoc. 3:101174. PubMed
  147. Teh MR, et al. 2021. Front Immunol. 12:714613. PubMed
  148. Stepanova E, et al. 2021. Microorganisms. 9:. PubMed
  149. Raju S, et al. 2020. Cell Reports. 29(9):2556-2564.e3.. PubMed
  150. Rosser EC, et al. 2020. Cell Metabolism. 31(4):837-851. PubMed
  151. Zenaro E, et al. 2009. J Leukoc Biol. 86:1393. PubMed
  152. Goodridge H, et al. 2009. J Immunol. 182:1146. PubMed
  153. Gnerlich J, et al. 2010. J Immunol. 185:4063. PubMed
  154. Boisvert M, et al. 2010. J Virol. 84:7782. PubMed
  155. Langkjær A, et al. 2012. Clin Immunol. 145:1. PubMed
  156. Rozková D, et al. 2009. Clin Immunol. 131:1. PubMed
  157. Miner M, et al. 2008. Microb Pathog. 45:273. PubMed
  158. Miller M, et al. 2014. Proc Natl Acad Sci U S A. 111:7397. PubMed
  159. Gartlan K, et al. 2015. Blood. 126: 1609-1620. PubMed
  160. Ulland T, et al. 2016. Nat Commun. 7:13180. PubMed
  161. Melacarne A, et al. 2021. Cell Reports. 36(1):109312. PubMed
  162. Tse SW, et al. 2021. Mol Ther. 29:2227. PubMed
  163. Cérbulo-Vázquez A, et al. 2022. PLoS One. 17:e0264566. PubMed
  164. Markey K, et al. 2009. Blood. 113:5644. PubMed
  165. Salazar V, et al. 2019. Cell Rep. 26:1585. PubMed
  166. Zischke J, et al. 2017. PLoS Pathogens. 13(6):e1006454. PubMed
  167. Theisen U, et al. 2020. J Cell Biol. :219. PubMed
  168. Dáňová K, et al. 2017. J Immunol. 198(2):729-740. PubMed
  169. Beyaz S, et al. 2016. Nat Immunol. 18:184-195. PubMed
  170. Kadivar M, et al. 2016. J Immunol. 197(12):4584-4592. PubMed
  171. Wang J, et al. 2013. J Virol. 87:11262. PubMed
  172. Ma Q, et al. 2022. Vaccines (Basel). 10:. PubMed
  173. Rhoades NS, et al. 2022. Cell Rep. 39:110725. PubMed
  174. Reuschl AK, et al. 2022. Cell Rep. 39:110650. PubMed
  175. Deng Y, et al. 2021. Nat Commun. 12:7041. PubMed
  176. Li Z, et al. 2021. JCI Insight. 6:. PubMed
  177. Virtakoivu R, et al. 2021. Clin Cancer Res. 27:4205. PubMed
  178. Koschel J, et al. 2021. Cell Death Differ. 28:2257. PubMed
  179. FitzPatrick MEB, et al. 2021. Cell Rep. 34:108661. PubMed
  180. Bass VL, et al. 2021. Mol Syst Biol. 17:e10127. PubMed
  181. Landi A, et al. 2017. Vaccine.. 10.1016/j.vaccine.2017.10.072. PubMed
  182. Fukuoka A, et al. 2013. Int Immunol. 25:373. PubMed
  183. Bulati M, et al. 2014. Exp Gerontol. 54:123. PubMed
  184. Zhou G, et al. 2014. J Cell Sci. 127:3916. PubMed
  185. Rist M, et al. 2015. J Virol. 89:703. PubMed
  186. Hoechst B, et al. 2016. J Immunol. 195:1517-1523. PubMed
  187. Festag J, et al. 2020. Mol Ther Nucleic Acids. 1.330555556. PubMed
  188. Mohammadpour H, et al. 2020. JCI Insight. 5:00. PubMed
  189. Gussarow D, et al. 2021. Front Med (Lausanne). 8:770381. PubMed
  190. Gebremeskel S, et al. 2017. Cancer Immunol Res. 0.9625. PubMed
  191. Kohn M, et al. 2021. Front Immunol. 626627:12. PubMed
  192. Bonavita E, et al. 2020. Immunity. 1215:53. PubMed
  193. Mackroth M, et al. 2016. PLoS Pathog. 12:e1005909. PubMed
  194. Rau M, et al. 2016. J Immunol. 196: 97 - 105. PubMed
  195. Olafsdottir TA, et al. 2022. Commun Biol. 5:914. PubMed
  196. Lei Y, et al. 2021. Sci Adv. 7:. PubMed
  197. van Loon K, et al. 2022. Cancers (Basel). 14:. PubMed
  198. Genardi S, et al. 2020. Front Immunol. 11:610010. PubMed
  199. Wang F, et al. 2021. Neoplasia. 23:281. PubMed
  200. Ruland C, et al. 2017. Brain Behav Immun. 10.1016/j.bbi.2017.06.010. PubMed
  201. Ahmadi H,et al. 2017. Inflammopharmacology. . 10.1007/s10787-017-0410-8. PubMed
  202. Li J, et al. 2018. Redox Biol. 0.976388889. PubMed
  203. Krishna B, et al. 2016. Sci Rep. 6: 24674. PubMed
  204. Schridde A, et al. 2017. Mucosal Immunol. 10.1038/mi.2016.142. PubMed
  205. Wang W, et al. 2020. STAR Protoc. 1:100218. PubMed
  206. Spiljar M, et al. 2021. Cell Metab. 33:2231. PubMed
  207. Lu G, et al. 2017. PLoS One. 12:e0178352. PubMed
  208. Orozco SL, et al. 2019. Cell Rep. 28:2275. PubMed
  209. Laczkó D, et al. 2020. Immunity. 53:724. PubMed
  210. Abshire C, et al. 2016. PLoS Pathog. 12:e1006088. PubMed
  211. Ikebuchi R, et al. 2016. Sci Rep. 6:35002. PubMed
  212. Ying B, et al. 2022. Sci Transl Med. 14:eabm3302. PubMed
  213. Guo Z, et al. 2022. Neurobiol Pain. 12:100096. PubMed
  214. Carrion B, et al. 2021. Neurol Neuroimmunol Neuroinflamm. 8:. PubMed
  215. Petrova T, et al. 2021. FEBS J. 288:5909. PubMed
  216. Nesterenko PA, et al. 2021. Proc Natl Acad Sci U S A. 118:. PubMed
  217. Matei DE, et al. 2021. Med (N Y). 2:864. PubMed

Antigen Details

Antigen References

1. Current Protocols in Immunology (John Wiley & Sons New York) Unit 6.24 Detection of Intracellular Cytokines by Flow Cytometry (Barbara Foster and Calman Prussin NIAID NIH Bethesda MD).
2. Sander B, et al. 1991. Immunol. Rev. 119:65.
3. Sander B, et al. 1993. J. Immunol. Meth. 166:201.
4. Prussin C, et al. 1995. J. Immunol. Meth. 188:117.
5. Jung T, et al. 1993. J. Immunol. Meth. 159:197.

Gene ID
NA

Related FAQs

The Brefeldin A solution freezes at 4°C . Is the solution still OK?

We recommend to thaw in warm water after removing from the fridge.  The Brefeldin A is dissolved in DMSO, which freezes at 18°C, so this is normal.  No one has reported any problems with the freeze/thaw cycles and this is how we recommend it is stored.   If customers are concerned, they can aliquot the Brefeldin A to avoid the freeze thaw.

How do I choose monensin or Brefeldin A solution?

Generally, Brefeldin A is more toxic for longer term incubations, so for shorter stimulations (6 hrs or less) use Brefeldin A.  For longer stimulations use monensin.  We recommend optimization for each cell type and protocol.

Go To Top Version: 1    Revision Date: 11/30/2012

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account